That being said, its important to manage your expectations
Understanding why GLP-1 therapy may not be effective for you is the first step towards finding the right solution, whether that involves optimising your current treatment, switching medications, or exploring alternative approaches tailored to your individual circumstances
Another GLP-1R agonist, liraglutide, has recently been approved as an anti-obesity drug because of abundant evidence of its prominent effect on weight loss (reviewed in van Bloemendaal et al [39])
Keime eindringen knnen oder die verabreichte Substanz selbst verursacht unerwnschte Wirkungen
However, research shows that intermittent fasting methods that involve skipping breakfast may increase stress (cortisol) levels, thus increasing the risk of cardiovascular disease
Consider dosage adjustments first